Human prothrombin complex (Boya Bio-Pharmaceutical)

人凝血酶原复合物（博雅生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex (Boya Bio-Pharmaceutical)
Drug Alias Name凝血酶原复合体浓缩物 - 博雅生物
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date2020/12/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBoya Bio-Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoya Bio-Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsHemophilia B

Other Information

ATC CodeB02BD01
Related LinksN/A